Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$331,521
+$171,014 QoQ
Shares Held
31,816
+21.9% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 95 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RNAC ranks #272 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in RNAC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $331,521 31,816
2026-03-31 $160,507 26,099
2025-12-31 $181,986 25,241
2025-09-30 $247,231 24,191
2025-06-30 $259,551 24,981
2025-03-31 $275,948 20,937
2024-12-31 $347,577 19,407
2024-09-30 $243,443 15,102
2024-06-30 $537,930 19,916
2024-03-31 $206,258 317,322
2023-12-31 $230,304 334,260
2023-09-30 $626,442 590,984
2023-06-30 $649,323 579,754
2023-03-31 $404,896 291,293
2022-12-31 $407,672 360,773
2022-09-30 $121,317 73,974
2022-06-30 $49,135 37,508
2022-03-31 $354,315 288,062
2021-12-31 $960,734 294,704
2021-09-30 $1,195,030 287,267
2021-06-30 $1,075,647 257,332
2021-03-31 $890,537 196,804
2020-12-31 $665,316 219,577
2020-09-30 $508,315 204,966
2020-06-30 $525,233 184,942